TY - JOUR
T1 - Acquired C1 esterase-inhibitor deficiency
T2 - Case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations
AU - Hentges, François
AU - Humbel, René
AU - Dicato, Mario
AU - Hemmer, Robert
AU - Kuntziger, Henri
N1 - Funding Information:
A case of severe angioedema with several episodes of life-threatening attack.-during a follow-up of 7 years is presented. Although the biologic profile is that of an acquired Cl INH dejciency, no lymphoproltferative malignancy or immune-complex disease could be proven until now. However, the patient has had a small monoclonal IgG A-gammopathy for 4 years. During the last 4 years, edematous manifestations have stopped. The patient now suffers at regular intervals of about a week from short-lasting attacks with digestive and vasomotor symptoms. This clinical evolution is accompanied by a worsening in the complement abnormalities. The digestive and vasomotor attacks were found to be correlated with sudden prekallikrein and high-molecular-weight kininogen consumption. These findings demonstrate that prekallikrein is activated during acquired CT INH deficiency and that the products of this pathway such as bradykinin are probably responsible for a part of the clinical manifestations associated with this disorder. (J ALLERGYC LINIMMJNOL7 8:860-7, 1986.) From the *Department of Imnnmo-Allergology and the **Labo-ratory of Biochemistry Centre Hospitalier of Luxembourg, Grand Duchy of Luxembourg. Supported by Grant 82-l 1 of the Society for Research on Cancer and Blood Disorders Luxembourg. Received for publication Nov. 1, 1985. Accepted for publication April 12, 1986. Reprint requests: Fran9ois Hentges, M.D., Department of Immuno-Allergology, Centre Hospitalier of Luxembourg, 4, Barble St., 1210 Luxembourg, G. Duchy of Luxembourg, Europe.
PY - 1986/11
Y1 - 1986/11
N2 - A case of severe angioedema with several episodes of life-threatening attacks faring a follow-up of 7 years is presented. Although the biologic profile is that of an acquired C1 ̄ INH deficiency, no lymphoproliferative malignancy or immune-complex disease could be proven until now. However, the patient has had a small monoclonal IgG λ-gammopathy for 4 years. During the last 4 years, edematous manifestations have stopped. The patient now suffers at regular intervals of about a week from short-lasting attacks with digestive and vasomotor symptoms. This clinical evolution is accompanied by a worsening in the complement abnormalities. The digestive and vasomotor attacks were found to be correlated with sudden prekallikrein and high-molecular-weight kininogen consumption. These findings demonstrate that prekallikrein is activated during acquired C1 ̄ INH deficiency and that the products of this pathway such as bradykinin are probably responsible for a part of the clinical manifestations associated with this disorder.
AB - A case of severe angioedema with several episodes of life-threatening attacks faring a follow-up of 7 years is presented. Although the biologic profile is that of an acquired C1 ̄ INH deficiency, no lymphoproliferative malignancy or immune-complex disease could be proven until now. However, the patient has had a small monoclonal IgG λ-gammopathy for 4 years. During the last 4 years, edematous manifestations have stopped. The patient now suffers at regular intervals of about a week from short-lasting attacks with digestive and vasomotor symptoms. This clinical evolution is accompanied by a worsening in the complement abnormalities. The digestive and vasomotor attacks were found to be correlated with sudden prekallikrein and high-molecular-weight kininogen consumption. These findings demonstrate that prekallikrein is activated during acquired C1 ̄ INH deficiency and that the products of this pathway such as bradykinin are probably responsible for a part of the clinical manifestations associated with this disorder.
UR - http://www.scopus.com/inward/record.url?scp=0022973044&partnerID=8YFLogxK
U2 - 10.1016/0091-6749(86)90231-9
DO - 10.1016/0091-6749(86)90231-9
M3 - Article
C2 - 3640782
AN - SCOPUS:0022973044
SN - 0091-6749
VL - 78
SP - 860
EP - 867
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 5 PART 1
ER -